Board of Directors

Dr. Joseph A. Miller, Jr.Chairman of the Board
Retired Executive Vice President and Chief Technology Officer
Corning, Inc.
Dr. Miller retired in April 2012 as Executive Vice President and Chief Technology Officer for Corning Inc., a position in which he had served since 2001. Dr. Miller served as a Director, and Chair of the Technology, Strategy and Investment Committee for Greatbatch Inc. and stepped down from the Greatbatch board of directors shortly before the completion of the Nuvectra spin-off. Before joining Corning, he served as Senior Vice President of E.I. DuPont de Nemours from 1999 to 2001 and held various executive positions with that company prior to that time. Dr. Miller has significant research and development knowledge and experience gained through his positions at Corning and E.I. DuPont. Dr. Miller serves as a director of Lightwave Logic, Inc. and previously served as a director of Dow Corning Corporation.
Scott F. DreesDirector
Chief Executive Officer
Nuvectra
Mr. Drees joined Nuvectra and has served as the company’s CEO since July of 2016. From 2008 until joining Nuvectra, Mr. Drees served as a founding partner of the QiG group and led the neuromodulation incubation team formed by Integer Holdings (formerly Greatbatch, Inc.) that created the Algovita (SCS) and Virtis (SNM) neurostimulation systems. In addition, from 2008 to 2015, Mr. Drees also served as the President and CEO of Neuromodulation Ventures, LLC, a private company focused solely on the neurostimulation industry. Mr. Drees has 37 years of experience in the medical device industry and has spent his last 22 years focused on neuromodulation markets and therapies. He served in executive positions from 1996-2006, as founding Division President and later Executive VP, Worldwide Sales & Marketing, at Advanced Neuromodulation Systems, Inc. (ANSI), a company acquired by St. Jude Medical, Inc., in 2005. Between 1981 and 1996, Mr. Drees held a variety of positions at St. Jude Medical, Boston Scientific, and Johnson and Johnson’s Codman Division. Mr. Drees earned his B.S. Degree from St. Joseph’s University, Philadelphia.
Anthony P. Bihl IIIDirector
Chief Executive Officer
Bioventus, LLC
Mr. Bihl has been Chief Executive Officer and a member of the Board of Managers of Bioventus, LLC, a company that develops, manufactures, and sells products that promote active orthopaedic healing, since December 2013. From June 2011 through June 2012, he was Group President of American Medical Systems, or AMS, a subsidiary of Endo Pharmaceuticals, or Endo. Mr. Bihl was President & Chief Executive Officer and a director of AMS from April 2008 until Endo acquired AMS in June 2011. He served as Chief Executive Officer of Siemens Medical Solutions’ Diagnostics Division from January to November 2007, and as President of the Diagnostics Division of Bayer HealthCare from 2004 through 2006. Prior to that, he served in a number of operations and finance roles at Bayer HealthCare, as well as more than 20 years at E.I. DuPont. He is a director and chairman of the board of Spectral Medical, Inc., a Canadian company that develops products for the diagnosis and treatment of severe sepsis and septic shock, and also serves as chair of its human resources and compensation committee. Mr. Bihl is a former director of SeraCare Life Sciences Inc.
Kenneth G. HawariDirector
Retired Executive Vice President – Corporate Development and General Counsel
Advanced Neuromodulation Systems
Mr. Hawari is currently an attorney and business consultant in private practice. From February 2002 until December 2006, he was Executive Vice President – Corporate Development and General Counsel for ANS. Prior to joining ANS, Mr. Hawari was an attorney at Hughes & Luce LLP (which subsequently became part of K&L Gates LLP) from 1984 until 2002. He currently serves as the chairman of the board for the North Texas Enterprise Center for Technology, Inc. (NTAC), which is a not-for-profit organization that assists and incubates medical and other technology based companies. Mr. Hawari earned his B.A. and a J.D. each from the University of Texas at Austin.
David D. JohnsonDirector
Retired Executive Vice President, Treasurer & Chief Financial Officer
Molex, LLC
From May 2005 until his retirement on February 1, 2016, Mr. Johnson served as the Executive Vice President, Treasurer & Chief Financial Officer of Molex, LLC (previously Molex Incorporated), which is a manufacturer of electronic connectors and components. He currently serves as a director, chairman of the audit committee, and member of the compensation committee of MTS Systems Corporation, which is a global supplier of test systems and industrial position sensors. Mr. Johnson earned his B.A. in economics from Stanford University and is a Certified Public Accountant (inactive status).
Dr. Fred B. Parks, PhDDirector
President and Chief Executive Officer
Analogic Corporation
Dr. Parks has served on Analogic’s Board of Directors since 2007 as the company transitioned into a market-leading, growth-oriented medical technology company. He has also served as the Executive Chairman and Chief Executive Officer of Enovate Medical since 2015. Dr. Parks previously served as Chief Executive Officer and Director of NDS Surgical Imaging, Inc., a provider of advanced medical visualization technology, from 2011 to 2013. He was also Chairman of the Board and Chief Executive Officer of Urologix, Inc., from 2003 to 2008. Prior to joining Urologix, Dr. Parks served as President and Chief Executive Officer of Marconi Medical Systems, a provider of advanced CT, MRI, and nuclear medicine imaging equipment, and following its acquisition by Royal Philips Electronics in 2001, led its integration into the Philips medical business. Previously, Dr. Parks held positions as President, Chief Operating Officer, and Board Member of St. Jude Medical, Inc., a medical device company focusing on implantable cardiovascular products, and as President, Chief Operating Officer, and Board Member of EG&G, Inc. (now PerkinElmer), a diversified technology company. Dr. Parks earned a B.S. in Mechanical Engineering from the University of Missouri-Rolla, an M.S. in Mechanical Engineering from the University of Arizona, and a Ph.D. in Mechanical Engineering from the University of Missouri.
Jon T. TremmelDirector
Retired President of Neurological Division
Medtronic plc
Until his retirement in 2007, Mr. Tremmel held several senior leadership positions with Medtronic plc, or Medtronic, including President of the Neurological Division from March 2003 to April 2007, President of the Physio-Control Division from May 2001 to March 2003, and President of the Tachyarrhythmia Management Division and President of the Interventional Vascular Division from 1992 to 2001. From 1978 until 1992, he served in various positions of increasing responsibility at Medtronic. He currently serves as a director EnteroMedics Inc., which is a publicly-traded medical device company, and Flowonix Medical, Inc., which is a privately-held medical device company. He previously served as a director of Nevro Corp., Cyberonics Inc., and ACell, Inc. Mr. Tremmel earned his B.S. in business and engineering from University of Minnesota, a Master’s degree in Engineering from Boston University, and an M.B.A. from University of Minnesota.
Thomas E. ZeliborDirector
Chief Executive Officer
U.S. Space Foundation
Mr. Zelibor is the Chief Executive Officer of the U.S. Space Foundation, a non-profit organization focused on inspiring, educating, connecting, and advocating on behalf of the global space community. In addition, he serves on several Boards of Directors including Lightwave Logic Inc., a public company focused on utilizing thin film polymers for electro-optic devices employed in the telecom and datacom markets where he is currently the Chairman of the Board and previously served as CEO from April 2012 to May 2017. Mr. Zelibor is also on the Board of Dienen Inc., a private medical device company focused on prosthetics and orthotics for the pediatrics market where he serves as the Chair of the Compensation Committee. Finally, he is a Director for Baker Street Scientific, a private company focused on artificial intelligence and machine learning. From July 2008 to April 2011, Mr. Zelibor was President and Chief Executive Officer of Flatirons Solutions Corp., a professional services and system engineering company. Prior to joining the private sector, Mr. Zelibor achieved the rank of Rear Admiral in the U.S. Navy and served in numerous senior positions, including Commander, Carrier Group Three, Navy CIO, and Director of Global Operations, United States Strategic Command.